Health-related Quality of Life of Bone Marrow versus Peripheral Blood Stem Cell Donors: A Prespecified Subgroup Analysis from a Phase III RCT-BMTCTN Protocol 0201

Biology of Blood and Marrow Transplantation

Volumn 20, Issue 1, 2014, Pages 118-127

  Switzer, Galen E ^a,b,c   Bruce, Jessica G ^b   Harrington, Donna ^b   Haagenson, Michael ^d,e   Drexler, Rebecca ^d   Foley, Amy ^d   Confer, Dennis ^d   Bishop, Michelle ^f   Anderlini, Paolo ^g   Rowley, Scott ^h   Leitman, Susan F ⁱ   Anasetti, Claudio ^j   Wingard, John R ^f  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH   (United States)

^e NATIONAL MARROW DONOR PROGRAM   (United States)

^f UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

ⁱ NATIONAL INSTITUTES OF HEALTH   (United States)

^j H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

more..

Author keywords

Marrow versus peripheral blood stem cell donation; Randomized trial; Unrelated hematopoietic stem cell donation

Indexed keywords

ADULT; ARTICLE; BLOOD DONOR; BONE MARROW; CONFUSION; COST BENEFIT ANALYSIS; FEMALE; HUMAN; MALE; PERIPHERAL BLOOD STEM CELL; PSYCHOLOGIC ASSESSMENT; QUALITY OF LIFE; SIDE EFFECT; SOCIAL BEHAVIOR; UNRELATED DONORS;

MARROW VERSUS PERIPHERAL BLOOD STEM CELL DONATION; RANDOMIZED TRIAL; UNRELATED HEMATOPOIETIC STEM CELL DONATION;

ADULT; BONE MARROW; BONE MARROW TRANSPLANTATION; FEMALE; HUMANS; LIVING DONORS; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROSPECTIVE STUDIES; QUALITY OF LIFE; SOCIAL CLASS; TISSUE AND ORGAN HARVESTING; UNRELATED DONORS;

EID: 84890948308     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2013.10.024     Document Type: Article

References (26)

1. National Marrow Donor Program and Be the Match Key Messages, Facts and Figures. Available at: http://marrow.org/News/Media/Facts_and_Figures_(PDF).aspx.
2. Favre G., Beksac M., Bacigalupo A., et al. Differences between graft product and donor side effects following bone marrow or stem cell donation. Bone Marrow Transplantation 2003, 32:873-880.
3. Halter J., Kodera Y., Ispizua A., et al. Severe events in donors after allogeneic hematopoietic stem cell donation. Haematologica 2009, 94:94-101.
4. Bolan C.D., Hartzman R.J., Perry E.H., et al. Donation activities and product integrity in unrelated donor allogeneic hematopoietic transplantation: experience of the National Marrow Donor Program. Biol Blood Marrow Transplant 2008, 14:23-28.
5. Holig K., Kramer M., Kroschinsky F., et al. Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of a single-center experience in 3928 donors. Blood 2009, 114:3757-3763.
6. Pulsipher M.A., Chitphakdithai P., Miller J.P., et al. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood 2009, 113:3604-3611.
7. Rinaldi C., Savignano C., Pasca S., et al. Efficacy and safety of peripheral blood stem cell mobilization and collection: a single-center experience in 190 allogeneic donors. Transfusion 2012, 52:2387-2394.
8. Miller J.P., Perry E.H., Price T.H., et al. Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donor Program. Biol Blood Marrow Transplant 2008, 14:29-36.
9. National Marrow Donor Program data. Available at: http://www.marrow.org.
10. Rowley S.D., Donaldson G., Lilleby K., et al. Experiences of donors enrolled in a randomized study of allogeneic bone marrow or peripheral blood stem cell transplantation. Blood 2001, 97:2541-2548.
11. Karlsson L., Quinlan D., Guo D., et al. Mobilized blood cells vs bone marrow harvest: experience compared in 171 donors with particular reference to pain and fatigue. Bone Marrow Transplantation 2004, 33:709-713.
12. Switzer G.E., Goycoolea J.M., Dew M.A., et al. Donating stimulated peripheral blood stem cells vs. bone marrow: do donors experience theprocedures differently?. Bone Marrow Transplantation 2001, 27:917-923.
13. Auguier P., Macquart-Moulin G., Moatti J.P., et al. Comparisons of anxiety, pain and discomfort in two procedures of hematopoietic stem cell collection: leukacytapheresis and bone marrow harvest. Bone Marrow Transplantation 1995, 16:541-547.
14. Anasetti C., Logan B.R., Lee S.J., et al. Peripheral blood stem cells versus bone marrow from unrelated donors: results of Blood and Marrow Transplant Clinical Trials Network protocol 0201, a phase II, prospective randomized trial. NEngl J Med 2012, 367:1487-1496.
15. Ware J.E., Kosinski M., Dewey J.E., Gandek B. How to Score and Interpret Single-Item Health Status Measures: A Manual for Users of the SF-8™ Health Survey 2001, QualityMetric Incorporated, Lincoln, RI.
16. Shacham S. Ashortened version of the Profile of Mood States. JPers Assess 1983, 47:305-306.
17. Curran S.L., Andrykowski M.A., Studts J.L. Short form of the Profile of Mood States (POMS-SF): psychometric information. Psychol Assess 1995, 7:80-83.
18. Switzer G.E., Simmons R.G., Dew M.A. Helping unrelated strangers: physical and psychological reactions to the bone marrow donation process among anonymous donors. JAppl Soc Psychol 1996, 26:469-490.
19. Switzer G.E., Dew M.A., Goycoolea J.M., et al. Attrition of potential bone marrow donors at two key decision points leading to donation. Transplantation 2004, 77:1529-1534.
20. Switzer G.E., Myaskovsky L., Goycoolea J.M., et al. Factors associated with ambivalence about bone marrow donation among newly recruited unrelated potential donors. Transplantation 2003, 75:1517-1523.
21. Switzer G.E., Dew M.A., Harrington D.J., et al. Ethnic differences in donation-related characteristics among potential hematopoietic stem cell donors. Transplantation 2005, 80:890-896.
22. Holm S. Asimple sequentially rejective multiple test procedure. Scand J Stat 1979, 6:65-70.
23. Bredeson C., Leger C., Couban S., et al. An evaluation of the donor experience in the Canadian multicenter randomized trial of bone marrow versus peripheral blood allografting. Biol Blood Marrow Transplant 2004, 10:405-414.
24. Fortanier C., Kuentz M., Sutton L., et al. Healthy sibling donor anxiety and pain during bone marrow or peripheral blood stem cell harvesting for allogeneic transplantation: results of a randomised study. Bone Marrow Transplantation 2002, 29:145-149.
25. Shaw B.E., Ball L., Beksac M., et al. Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical andethical considerations. Bone Marrow Transplantation 2010, 45:832-838.
26. Pulsipher M.A., Chitphakdithai P., Logan B.R., et al. Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program. Blood 2013, 121:197-206.